Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Nihon Pharma is a Japanese pharmaceutical company that specializes in the development, manufacture, and sale of plasma-derived medicinal products and gastrointestinal treatments. As a wholly-owned subsidiary of Takeda Pharmaceutical Company, it serves as a core component of Takeda's plasma-derived therapies business in the Japanese market. The company's portfolio includes essential treatments such as immunoglobulins, albumin, and blood coagulation factors, as well as specialized agents for endoscopic procedures. Nihon Pharma operates multiple manufacturing facilities in Japan, including the Narita and Izumisano plants, which adhere to rigorous safety and quality standards for biological products. Founded in 1947, the company maintains a long-standing reputation for providing critical care medicines and diagnostic aids to the healthcare sector.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Nihon Pharma.